How brain GLP-1 controls appetite and body weight

Synaptic and circuit mechanisms of central GLP-1 signaling in energy balance

NIH-funded research Rutgers Biomedical and Health Sciences · NIH-11330270

This project looks at how a brain hormone called GLP-1 controls hunger and body weight to help people with obesity and type 2 diabetes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRutgers Biomedical and Health Sciences NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project IDNIH-11330270 on NIH RePORTER

What this research studies

If you have obesity or diabetes, this work aims to map how a brain hormone called GLP-1 changes hunger and body weight. The team will use animal models and specialized molecular tools to detect when and where GLP-1 is released in the brain and which nerve cells it acts on. They will manipulate specific neurons and brain circuits and measure effects on eating, synaptic signaling, and body weight. The goal is to find precise brain targets that could guide future treatments.

Who could benefit from this research

Good fit: Adults with overweight/obesity or type 2 diabetes who are interested in future therapies targeting brain GLP-1 signaling.

Not a fit: People without metabolic disease or those seeking immediate clinical treatment are unlikely to benefit directly from this laboratory-focused work.

Why it matters

Potential benefit: Could point to new, more targeted ways to reduce appetite and body weight with potentially fewer side effects than current treatments.

How similar studies have performed: Drugs that mimic GLP-1 already help many people lose weight and control blood sugar, but the specific brain circuit mechanisms this project targets are less well understood and remain experimental.

Where this research is happening

Newark, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Adult-Onset Diabetes Mellitus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.